EscharEx® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 ...
Clashing over the etiquette and economics of showing up late to skip the pre-movie barrage of commercials and trailers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results